Strategic Wealth Partners, Ltd. Eli Lilly & CO Transaction History

Strategic Wealth Partners, Ltd.

$892 Million
Q1 2024

A detailed history of Strategic Wealth Partners, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 10,713 shares of LLY stock, worth $9.7 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

10,713

Previous 9,731 10.09%

Holding current value

$9.7 Million

Previous $5.67 Million 46.93%

% of portfolio

0.93%

Previous 0.7%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$592.2 - $792.28 $581,540 - $778,018	982 Added 10.09%	10,713 $8.33 Million
Q4 2023 May 20, 2024	SELL	$525.19 - $619.13 $495,254 - $583,839	-943 Reduced 8.83%	9,731 $5.67 Million
Q3 2023 May 20, 2024	BUY	$434.7 - $599.3 $253,430 - $349,391	583 Added 5.78%	10,674 $5.73 Million
Q2 2023 May 20, 2024	SELL	$350.74 - $468.98 $111,886 - $149,604	-319 Reduced 3.06%	10,091 $4.73 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $140,404 - $164,898	452 Added 4.54%	10,410 $3.58 Million

Q4 2022 Apr 24, 2023	BUY	$321.55 - $374.67 $628,951 - $732,854	1,956 Added 24.44%	9,958 $3.64 Million
Q3 2022 Apr 24, 2023	BUY	$296.48 - $337.87 $121,260 - $138,188	409 Added 5.39%	8,002 $2.59 Million
Q2 2022 Aug 22, 2022	SELL	$278.73 - $327.27 $578,643 - $679,412	-2,076 Reduced 21.47%	7,593 $2.46 Million
Q1 2022 May 19, 2022	BUY	$234.69 - $291.66 $509,511 - $633,193	2,171 Added 28.95%	9,669 $2.77 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $80,496 - $99,896	358 Added 5.01%	7,498 $2.07 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $113,680 - $139,900	513 Added 7.74%	7,140 $1.65 Million
Q2 2021 Aug 25, 2021	BUY	$180.55 - $233.54 $367,419 - $475,253	2,035 Added 44.32%	6,627 $1.52 Million
Q1 2021 May 24, 2021	SELL	$164.32 - $212.72 $40,751 - $52,754	-248 Reduced 5.12%	4,592 $858,000
Q4 2020 Feb 18, 2021	SELL	$130.46 - $172.63 $18,655 - $24,686	-143 Reduced 2.87%	4,840 $817,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $264,073 - $305,448	1,806 Added 56.85%	4,983 $738,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $433,406 - $521,599	3,177 New	3,177 $522,000
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $8,125 - $10,064	-76 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $6,315 - $7,371	-57 Reduced 42.86%	76 $8,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $9,461 - $11,136	85 Added 177.08%	133 $17,000
Q2 2018 Sep 04, 2018	SELL	$75.7 - $86.88 $23,012 - $26,411	-304 Reduced 86.36%	48 $4,000
Q1 2018 Jul 13, 2018	BUY	$74.21 - $87.6 $26,121 - $30,835	352 New	352 $27,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account

Strategic Wealth Partners, Ltd. Eli Lilly & CO Transaction History